The MessyCheffy project won the challenge launched by the PCB, the IBEC and the IRB in the iFest Countdown Blog Post

MessyCheffy, an interactive physiotherapy game for children with muscular dystrophy, developed by the Yallow team from the University of Barcelona, has won the “Rare Diseases” challenge set by the Barcelona Science Park, the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona) as part of the iFest Countdown initiative. The young finalists of this programme presented their prototypes to a panel at the Auditorium Imagina Mediapro today at the iFest Demo Day, during an event chaired by the director of Catalunya Emprèn, Pere Condom. 

 

CataloniaBio & HealthTech and Boston MassMEDIC join forces Blog Post

CataloniaBio & HealthTech –the association of companies in the biomedicine and health arena in Catalonia, based in the Barcelona Science Park– and the Massachusetts Medical Device Industry Council (MassMEDIC), the largest association of medical technology companies in the United States, have signed an agreement to foster innovation and collaborations in business and research among their members. 

 

GlyCardial Diagnostics receives the EmprendedorXXI Award in Catalonia Blog Post

The companies GlyCardial Diagnostics, based in the Barcelona Science Park, and Mitiga Solutions, have been honoured with the EmprendedorXXI Award in Catalonia, which is promoted by CaixaBank –through DayOne, its specialized division that provides banking services for technology and innovation companies and its investors- and awarded jointly by the Ministry of Industry, Commerce and Tourism, through Empresa Nacional de Innovación, S.A. (ENISA). The award ceremony was held yesterday in the Recinte Modernista of the Hospital de Sant Pau as part of the ‘DayOne Innovation Summit’ event. Outside of the regional prize, next May 14th the sectorial EntrepreneurXXI Awards will be awarded to 6 nationwide companies with the highest growth potential in their sector.

 

Esteve’s R&D&I has once again received the qualification ”Excellent” in the Profarma program Blog Post

Once again, Esteve‘s research activity has received the qualification ”Excellent” in the 2018 call of the Profarma program, resolved by the Spanish Ministry of Industry, Commerce and Tourism.The pharmaceutical group – that in 2012 established its key units for the discovery of drugs and preclinical development in the Barcelona Science Park– has been recognized with the highest rating for its commitment to innovation and quality of its research.

 

The PCB participates in a new edition of iFest: the festival of technology, science and disruptive innovation Blog Post

iFest, an event promoted by Catalunya Emprèn which brings young people closer to science, technology and disruptive innovation, is getting ready for a new edition, which will be preceded this year by a four-month learning and mentoring process, the iFest Countdown. During this programme, players will develop prototypes responding to real-life challenges proposed by various entities—including the Barcelona Science Park (PCB), the Institute for Bioengineering of Catalonia (IBEC) and the Institute of Biomedical Research (IRB Barcelona). In 2019’s iFest Zero, each team will have to defend their project and compete with other participants.

 

Tumor cell expansion challenges current physics Blog Post

The journal Nature Physics published a study by a team led by Xavier Trepat, ICREA researcher at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park and lecturer at the Department of Biomedicine University of Barcelona (UB), and Jaume Casademunt, professor of Physics at the UB, reveals the forces these tumor cells use to spread. The relation between these forces and the cell movement goes beyond current physical laws. 

 

Barcelona Science Park celebrates 20 years as a scientific and business innovation centre Blog Post

Yesterday, Barcelona Science Park (Parc Científic de Barcelona, PCB) held the first of a number of events scheduled to commemorate its 20 years as a meeting place for universities, companies and society. Established by the University of Barcelona (UB) in 1997 with the mission of promoting formulas to enhance research excellence, knowledge transfer and entrepreneurship, it was the first science park in Spain. Twenty years after the first brick was laid, the Barcelona Science Park is now one of Europe’s leading science, technology and business innovation parks for life sciences. Covering an area of over 100,000 m2, it boasts a wide range of scientific and technological infrastructures and an innovative community made up of more than 100 public and private entities and 2,700 professionals

 

Genesis Ventures selects the NeuroHeal project by the UAB’s Neurosciences Institute for its first investment Blog Post

The Genesis Ventures fund—managed by the consultancy firm Genesis Biomed headquartered in the Barcelona Science Park—has secured its first deal with its investment of €75,000 in the NeuroHeal project, a new pharmacological combination that accelerates nerve regeneration, developed at the Neurosciences Institute (INc) of the Autonomous University of Barcelona (UAB). 

 

Scientific and Technological Centers UB: 30 years of technology serving research and innovation Blog Post

The Scientific and Technological Centers of the University of Barcelona (CCiTUB) reached their first thirty years of activity over which they have become widely known in both the national and international fields of research, innovation, and transfer. At the moment, the team in CCiTUB is formed by a hundred and sixty experts and administration staff, and eighty of tem are doctors, distributed in thirty-eight units, six of which are located in the Barcelona Science Park (PCB), among which there is the Nuclear Magnetic Resonance Laboratory (LRB), listed in the Map of Unique Scientific and Technical Infraestructures (ICTS). 

 

The Fem Talent 2018 Awards recognize Judit Anido and ProteoDesign Blog Post

Two companies based in the Barcelona Science Park have been recognized in this year’s edition of the Fem Talent awards. Dr Judit Anido, co-founder and CEO of Mosaic Biomedicals, has received the “Emerging Talent” award, and the company ProteoDesign –created by Silvia Frutos, Miquel Vila-Perelló, Silvia Frutos, Marc Montserrat and Tom W. Muir– has been a finalist in the ‘Organisation with Fem Talent Values’ category.